Format

Send to

Choose Destination
Cell Biosci. 2016 Aug 30;6(1):50. doi: 10.1186/s13578-016-0111-9. eCollection 2016.

Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway.

Author information

1
Department of Biomedical Science, College of Life Science, CHA University, 689 Sampyeong-dong, Bundang-gu, Seongnam, 463-400 Republic of Korea.
2
Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON L8N 3Z5 Canada.
3
Department of Internal Medicine, School of Medicine, Kangwon National University, Kangwondaehakgil 1, Chuncheon, Gangwon 200-701 Republic of Korea.
4
Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.
5
Stem Cell Institute, Kangwon National University, Chuncheon, Republic of Korea.
6
Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.
7
Department of Physiology, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.
8
Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.
#
Contributed equally

Abstract

BACKGROUND:

Aside from its importance in reproduction, estrogen (E2) is known to regulate the proliferation and differentiation of hematopoietic stem cells in rodents. However, the regulatory role of E2 in human hematopoietic system has not been investigated. The purpose of this study is to investigate the effect of E2 on hematopoietic differentiation using human pluripotent stem cells (hPSCs).

RESULTS:

E2 improved hematopoietic differentiation of hPSCs via estrogen receptor alpha (ER-α)-dependent pathway. During hematopoietic differentiation of hPSCs, ER-α is persistently maintained and hematopoietic phenotypes (CD34 and CD45) were exclusively detected in ER-α positive cells. Interestingly, continuous E2 signaling is required to promote hematopoietic output from hPSCs. Supplementation of E2 or an ER-α selective agonist significantly increased the number of hemangioblasts and hematopoietic progenitors, and subsequent erythropoiesis, whereas ER-β selective agonist did not. Furthermore, ICI 182,780 (ER antagonist) completely abrogated the E2-induced hematopoietic augmentation. Not only from hPSCs but also from human umbilical cord bloods, does E2 signaling potentiate hematopoietic development, suggesting universal function of E2 on hematopoiesis.

CONCLUSIONS:

Our study identifies E2 as positive regulator of human hematopoiesis and suggests that endocrine factors such as E2 influence the behavior of hematopoietic stem cells in various physiological conditions.

KEYWORDS:

Erythrocytes; Estrogen; Hematopoiesis; Human pluripotent stem cells

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center